EGFR GENE OVEREXPRESSION
Clinical trials for EGFR GENE OVEREXPRESSION explained in plain language.
Never miss a new study
Get alerted when new EGFR GENE OVEREXPRESSION trials appear
Sign up with your email to follow new studies for EGFR GENE OVEREXPRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double attack on EGFR-Positive tumors: targeted drug plus immunotherapy combo tested
Disease control Recruiting nowThis phase II trial tests a combination of two drugs—becotatug vedotin, which targets cancer cells with high levels of EGFR, and pucotenlimab, which helps the immune system attack tumors—in people with advanced solid tumors that have not responded to standard treatments. The stud…
Matched conditions: EGFR GENE OVEREXPRESSION
Phase: PHASE2 • Sponsor: Tianjin Medical University Second Hospital • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New hope for glioblastoma: drug infused directly into brain shows promise
Disease control Recruiting nowThis trial tests a new way to treat glioblastoma, an aggressive brain cancer. The drug cetuximab, which blocks a protein that helps tumors grow, is infused directly into the brain's arteries after temporarily opening the blood-brain barrier. Up to 33 newly diagnosed patients will…
Matched conditions: EGFR GENE OVEREXPRESSION
Phase: PHASE1, PHASE2 • Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC